Great article. "To maximize shareholder value, Nemus is open to explore strategic collaborations with partners that can help expedite our goals to commercialize our pipeline. That collaboration could possibly take the form of a co-development deal, an in-licensing of our products, or an outright acquisition of a promising platform, especially one that requires resources that an early-stage biotechnology company may not have."
"Nemus has licenses from the University of Mississippi that allow the company to develop unique methods to administer our novel forms of cannabinoids and we look forward to introducing these approaches into the development pipeline in 2017."
News 
Market Data 
Discover 
AI
